SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDE.L Regulatory News (IDE)

  • There is currently no data for IDE

Accelerated Bookbuild

8 Mar 2012 15:40

RNS Number : 9972Y
Cupid PLC
08 March 2012
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

 

Cupid plc

 

(the "Company" or "Cupid")

 

PROPOSED PLACING OF ORDINARY SHARES

 

The Company announces that it has been advised by Max Polyakov, consultant and former Director of the Company, and Bill Dobbie, Chief Executive Officer, that each intend to sell up to 6 million ordinary shares in the Company of 2.5p each ("Shares") via an accelerated bookbuild (the "Placing"). This represents, in aggregate, approximately 14.8 per cent. of the issued share capital of Cupid. The Shares held by Mr Polyakov are held through Opalta Limited ("Opalta").

Assuming that the above number of Shares are sold, Max Polyakov, through Opalta, will hold 12,569,208 Shares and Bill Dobbie will hold 13,811,053 Shares, representing respectively 15.5% and 17.0% of the issued share capital of the Company.

 

The Placing is being managed by Peel Hunt as sole Broker. The number of Shares in the Placing and the Placing price will be decided at the close of the accelerated bookbuilding period. 

 

The book for the Placing will open with immediate effect. Pricing is expected to be announced as soon as practicable following the closing of the books. The timing of closing of the books will be at the absolute discretion of Peel Hunt.

 

Max Polyakov (and his associated persons) is, save in respect of certain exceptional circumstances, subject to a hard lock-in, prohibiting the sale of his Shares until 30 June 2013 and thereafter subject to an orderly market arrangement until 30 June 2014 such that any disposals of Shares must be made through the Company's broker from time to time and otherwise with the consent of the Company and its broker.

 

For further information please contact:

 

Cupid plc

Tel: +44 (0)131 220 1313

Mark Doughty, CFO

Peel Hunt LLP (Nominated Adviser and Broker)

Tel: +44 (0)207 418 8900

Richard Kauffer

Daniel Harris

Redleaf Polhill

Tel: +44 (0)207 566 6720

Henry Columbine

Luis Mackness

cupid@redleafpolhill.com

 

Peel Hunt LLP is acting on the Placing and will not be responsible to anyone other than its client for providing the protections afforded to its clients, nor for providing advice in relation to the Placing, the contents of this announcement, or any transaction or arrangement referred to herein.

This announcement is for information purposes only and does not constitute or form part of an offer or invitation to acquire or dispose of any securities of Cupid, or constitute a solicitation of any offer to purchase or subscribe for securities in any jurisdiction, including the United States, Canada, Australia or Japan. Cupid's shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under the securities legislation of any state of the United States and may not be offered or sold in the United States absent registration or an exemption from registration.

Cupid's shares may not, directly or indirectly, be offered or sold within the United States, Canada, Australia or Japan or offered or sold to a resident of Canada, Australia or Japan. No public offering of securities is being made in the United States.

This announcement is not for publication or distribution to persons in the United States of America, its territories or possessions or to any US person (within the meaning of Regulation S under the US Securities Act of 1933, as amended). Neither this announcement nor any copy of it may be taken or transmitted into Australia, Canada or Japan or to Canadian persons or to any securities analyst or other person in any of those jurisdictions. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian or Japanese securities law. The distribution of this announcement in certain other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

This announcement and any offer of securities to which it relates are only addressed to and directed at persons who are (1) qualified investors within the meaning of directive 2003/71/ec and any relevant implementing measures (the prospectus directive) and (2) who have professional experience in matters relating to investments who fall within article 19(1) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or are persons falling within article 49(2)(a) to (d) ("High Net Worth Companies, Unincorporated Associations, etc") of the Order (all such persons together being referred to as "relevant persons"). The information regarding the Placing set out in this announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJPMATMBJMBAT
Date   Source Headline
20th Apr 20217:00 amRNSDirectorate Change
15th Feb 20217:00 amRNSResignation of Director
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 202111:06 amRNSSecond Price Monitoring Extn
1st Feb 202111:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSTrading Update
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:00 pmRNSPrice Monitoring Extension
28th Jan 202111:05 amRNSSecond Price Monitoring Extn
28th Jan 202111:00 amRNSPrice Monitoring Extension
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:35 pmRNSPrice Monitoring Extension
4th Jan 20219:05 amRNSSecond Price Monitoring Extn
4th Jan 20219:00 amRNSPrice Monitoring Extension
4th Jan 20217:00 amRNSContract Win
24th Dec 202011:06 amRNSSecond Price Monitoring Extn
24th Dec 202011:00 amRNSPrice Monitoring Extension
24th Dec 20209:05 amRNSSecond Price Monitoring Extn
24th Dec 20209:00 amRNSPrice Monitoring Extension
4th Dec 20202:06 pmRNSSecond Price Monitoring Extn
4th Dec 20202:00 pmRNSPrice Monitoring Extension
3rd Dec 20204:40 pmRNSSecond Price Monitoring Extn
3rd Dec 20204:35 pmRNSPrice Monitoring Extension
2nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20204:36 pmRNSPrice Monitoring Extension
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:01 pmRNSPrice Monitoring Extension
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:00 amRNSPrice Monitoring Extension
2nd Dec 20209:05 amRNSSecond Price Monitoring Extn
2nd Dec 20209:00 amRNSPrice Monitoring Extension
20th Nov 20202:06 pmRNSSecond Price Monitoring Extn
20th Nov 20202:01 pmRNSPrice Monitoring Extension
16th Nov 202010:11 amRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSHalf-year Report
4th Sep 202011:24 amRNSResult of AGM
10th Aug 202012:05 pmRNSNotice of Annual General Meeting
14th Jul 20207:00 amRNSFinal Results
30th Jun 20207:00 amRNSDelay of Full Year Results and Trading Update
5th Jun 202012:17 pmRNSChange of Directorate Position
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
24th Feb 20202:16 pmRNSHolding(s) in Company
20th Feb 20203:24 pmRNSDirector/PDMR Shareholding
15th Jan 20202:32 pmRNSDirector/PDMR Shareholding
30th Dec 20197:00 amRNSIssue of Loan Notes and Contract Wins
13th Nov 20199:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.